Cannabis Bioscience International Holdings (CBIH) Other Operating Expenses (2022 - 2026)

Cannabis Bioscience International Holdings has disclosed Other Operating Expenses across 5 years of filings, most recently posting $62139.0 for Q1 2026.

• Other Operating Expenses for Q1 2026 came in at $62139.0, up 1.68% year-over-year; the trailing twelve-month figure through Feb 2026 was $414264.0 (up 7.44% YoY), and the FY2025 annual result was $516557.0, up 8.33% from the prior year.
• Other Operating Expenses came in at $62139.0 for Q1 2026 at Cannabis Bioscience International Holdings, down from $96270.0 in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $241961.0 in Q1 2023 to a low of $56261.0 in Q3 2025.
• The 5-year median for Other Operating Expenses is $122386.0 (2023), against an average of $134840.0.
• Peak annual rise in Other Operating Expenses reached 190.92% in 2025, while the deepest fall reached 70.14% in 2025.
• Cannabis Bioscience International Holdings' Other Operating Expenses stood at $218680.0 in 2022, then plunged by 52.74% to $103354.0 in 2023, then plunged by 34.78% to $67408.0 in 2024, then soared by 42.82% to $96270.0 in 2025, then sank by 35.45% to $62139.0 in 2026.
• The last three Other Operating Expenses figures came in at $62139.0 (Q1 2026), $96270.0 (Q4 2025), and $56261.0 (Q3 2025), per Business Quant data.